Where is KOELIS located?

KOELIS is headquartered in Meylan, France.

Who is the current CEO of KOELIS?

Antoine Leroy of KOELIS. They have also founded 1 company.

Which legal entities is KOELIS associated with?

KOELIS is associated with Koelis.

How many employees does KOELIS have?

As of Jul 31, 2026, the latest employee count at KOELIS is 124.

What is the annual revenue of KOELIS?

Annual revenue of KOELIS is between €10M and €50M as on Dec 31, 2024

Where does KOELIS rank among its competitors?

KOELIS ranks 3rd amongst 17 active competitors, of which 4 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Exact Imaging, which secured $10M in Feb, 2026.

Who are the top competitors of KOELIS?

KOELIS's top competitors include Profound Medical, Exact Imaging and BotImage. Among them, Exact Imaging secured the most recent funding round in February, 2026.

KOELIS - 2026 Company Profile, Team, Funding, Competitors & Financials

KOELIS is an acquired company based in Meylan (France), founded in 2006 by Antoine Leroy and Patrick Henri. It operates as a Developer of MRI/Ultrasound fusion biopsy system for personalized prostate care. The company has 17 active competitors, including 4 funded and 4 that have exited. Its top competitors include companies like Profound Medical, Exact Imaging and BotImage.

Company Details

Developer of MRI/Ultrasound fusion biopsy system for personalized prostate care. The system provides needle guidance, supporting physicians in diagnosis and treatment. The technology tracks the prostate and records core locations, allowing targeted biopsies. It also offers ultrasound platform that compensates for prostate and patient movement.

Website: koelis.com
Social
Phone Number: +33 **********

Key Metrics

Founded Year

2006

Location

Meylan, France

Stage

Acquired

Investors

MEDEVICE

Ranked

3^rd among 17 active competitors

Annual Revenue

€10M - €50M as on Dec 31, 2024

Employee Count

124 as on Jul 31, 2026

Similar Companies

Profound Medical & 18 more

Exit Details

Acquired by InnovaHealth Partners (Sep 17, 2019)

View KOELIS's full profile

KOELIS is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Koelis CIN: 492218375 , France, Active	Jun 10, 2006	€10M - €50M (As on Dec 31, 2024)	-	-

KOELIS got acquired by InnovaHealth Partners on Sep 17, 2019.

Click here to take a look at KOELIS's acquisition in detail

KOELIS is a funded company. KOELIS has 1 institutional investor.

View details of KOELIS's funding rounds and investors

The founders of KOELIS are Antoine Leroy and Patrick Henri. Antoine Leroy is the CEO of KOELIS.

Here are the details of KOELIS's key team members:

Antoine Leroy: Co-Founder & CEO of KOELIS.
Patrick Henri: Co-Founder of KOELIS.

View details of KOELIS's Founder profiles and Board Members

KOELIS's employee count trend

KOELIS has 124 employees as of Jul 26. Here is KOELIS's employee count trend over the years:

Uncover KOELIS's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of KOELIS include Profound Medical, Exact Imaging and BotImage. Here is the list of Top 10 competitors of KOELIS, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Profound Medical 2008, Toronto (Canada), Public	Developer of image guided prostate ablation system for cancer treatment	$37.7M	Genesys Capital, BDC & 11 others	65/100
2nd	Exact Imaging 2013, Markham (Canada), Series D	Developer of micro-ultrasound based imaging device	$39.9M	iGan Partners, Lumira Ventures & 9 others	57/100
3rd	KOELIS 2006, Meylan (France), Acquired	Developer of MRI/Ultrasound fusion biopsy system for personalized prostate care	-	MEDEVICE	49/100
4th	BotImage 2019, Omaha (United States), Seed	Provider of AI-based image interpretation for MRI for prostrate cancer detection	$5.17M	-	47/100
5th	Exact Imaging 2003, Las Vegas (United States), Acquired	Micro-ultrasound systems for targeted prostate biopsies and urological imaging	$4.2M	Veddis App, iGan Partners	32/100
6th	Uromedtech 2023, Singapore (Singapore), Acquired	Developer of imaging equipment for prostate biopsy procedures	-	-	31/100
7th	OmnEcoil Instruments 2016, Portland (United States), Funding Raised	Developing the device for tissue sampling and prostate cancer detection	-	OTRADI, America’s Seed Fund & 2 others	30/100
8th	Triopsy 2012, Aurora (United States), Seed	Developer of medical device for cancer diagnosis	$4.14M	Colorado Office of Economic Development and International Trade ... Read more	29/100
9th	Focal Healthcare 2014, Toronto (Canada), Seed	Guidance system for prostate biopsy	$870K	Canadian Space Agency	28/100
10th	Vigeo 2005, Virgilio (Italy), Unfunded	Biopsy devices for prostrate and breast cancer	-	-	27/100